Noonan Syndrome and Celiac Disease in an Adolescent With Short Stature and Delayed Puberty

Q3 Medicine
{"title":"Noonan Syndrome and Celiac Disease in an Adolescent With Short Stature and Delayed Puberty","authors":"","doi":"10.1016/j.aace.2024.05.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Background/Objective</h3><p>We present an adolescent male with Noonan syndrome (NS) and celiac disease (CD) who attained normal adult height with growth hormone (GH) treatment and gluten-free diet (GFD).</p></div><div><h3>Case Report</h3><p>A 15 ½ year old healthy male presented with short stature and delayed puberty. His mother and maternal grandmother were short with heights 142.2 cm and 147.3 cm, respectively. Examination showed bilateral epicanthal folds and down slanting eyes like his mother, fifth finger clinodactyly, height 147.5 cm (&lt;1%; standard deviation score, −2.96), growth velocity 2.5 cm/y, weight 48.2 kg (11%; standard deviation score, −1.24), Tanner 2 pubic hair and Tanner 1 genitalia. Midparental target height was 169.1 cm. He had normal screening studies for GH deficiency and thyroid disorders, prepubertal gonadotropins and testosterone levels, and normal total immunoglobulin A, and elevated antitissue transglutaminase immunoglobulin A 134.7units/mL (0-20). Bone age was 13 years. Genetic evaluation revealed heterozygous missense variant of <em>BRAF</em> gene in him and his mother confirming a diagnosis of NS. He was diagnosed with CD by intestinal biopsy. Patient was started on GH therapy and a GFD with subsequent improvement in growth velocit (6.8-12.3 cm/y) and advancement of puberty. The patient stopped GH therapy at 17 ½ years with a height 165.9 cm.</p></div><div><h3>Discussion</h3><p>Coexistence of NS caused by <em>BRAF</em> missense variant and CD has not been previously reported. Our patient attained normal adult height with GH therapy and GFD.</p></div><div><h3>Conclusion</h3><p>NS and CD can co-occur and addressing both these disorders can help patients attain normal height potential.</p></div>","PeriodicalId":7051,"journal":{"name":"AACE Clinical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2376060524000476/pdfft?md5=004ad85fce71f9dab13ce526064a2153&pid=1-s2.0-S2376060524000476-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AACE Clinical Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2376060524000476","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background/Objective

We present an adolescent male with Noonan syndrome (NS) and celiac disease (CD) who attained normal adult height with growth hormone (GH) treatment and gluten-free diet (GFD).

Case Report

A 15 ½ year old healthy male presented with short stature and delayed puberty. His mother and maternal grandmother were short with heights 142.2 cm and 147.3 cm, respectively. Examination showed bilateral epicanthal folds and down slanting eyes like his mother, fifth finger clinodactyly, height 147.5 cm (<1%; standard deviation score, −2.96), growth velocity 2.5 cm/y, weight 48.2 kg (11%; standard deviation score, −1.24), Tanner 2 pubic hair and Tanner 1 genitalia. Midparental target height was 169.1 cm. He had normal screening studies for GH deficiency and thyroid disorders, prepubertal gonadotropins and testosterone levels, and normal total immunoglobulin A, and elevated antitissue transglutaminase immunoglobulin A 134.7units/mL (0-20). Bone age was 13 years. Genetic evaluation revealed heterozygous missense variant of BRAF gene in him and his mother confirming a diagnosis of NS. He was diagnosed with CD by intestinal biopsy. Patient was started on GH therapy and a GFD with subsequent improvement in growth velocit (6.8-12.3 cm/y) and advancement of puberty. The patient stopped GH therapy at 17 ½ years with a height 165.9 cm.

Discussion

Coexistence of NS caused by BRAF missense variant and CD has not been previously reported. Our patient attained normal adult height with GH therapy and GFD.

Conclusion

NS and CD can co-occur and addressing both these disorders can help patients attain normal height potential.

一名身材矮小、青春期延迟的青少年患有努南综合征和乳糜泻
背景/目的我们介绍了一名患有努南综合征(NS)和乳糜泻(CD)的青少年男性患者,通过生长激素(GH)治疗和无麸质饮食(GFD),他的成年身高达到了正常水平。他的母亲和外祖母身高分别为 142.2 厘米和 147.3 厘米。检查结果显示,他和母亲一样有双侧上睑皱褶和下斜眼,五指挛缩,身高 147.5 厘米(<1%;标准偏差分值,-2.96),生长速度 2.5 厘米/年,体重 48.2 千克(11%;标准偏差分值,-1.24),阴毛为 Tanner 2 型,生殖器为 Tanner 1 型。父母的目标身高为 169.1 厘米。他的 GH 缺乏症和甲状腺疾病筛查结果正常,青春期前促性腺激素和睾酮水平正常,总免疫球蛋白 A 正常,抗组织转谷氨酰胺酶免疫球蛋白 A 升高,为 134.7 单位/毫升(0-20)。骨龄为 13 岁。遗传学评估显示,他和他母亲的 BRAF 基因存在杂合错义变异,确诊为 NS。通过肠道活检,他被诊断为 CD。患者开始接受 GH 治疗和 GFD,随后生长速度得到改善(6.8-12.3 厘米/年),青春期提前。患者在 17 岁半时停止了 GH 治疗,身高达到 165.9 厘米。结论NS和CD可同时存在,解决这两种疾病可帮助患者获得正常的身高潜能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
AACE Clinical Case Reports
AACE Clinical Case Reports Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
2.30
自引率
0.00%
发文量
61
审稿时长
55 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信